 |
|
Estrogen and Heart Disease: Alternatives to a Paradigm in Crisis
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Hsia et al1 conclude that neither estrogen alone nor estrogen combined with continuous medroxyprogesterone acetate provide protection against coronary heart disease in postmenopausal women in a report of the final results of the Women's Health Initiative (WHI) trial of cardioprotection by hormone therapy. They suggest that, "The views of both the medical and lay communities regarding the role of exogenous estrogen during and after menopause remain in evolution during the current paradigm shift."1(p364)
The traditional view was that female hormones protect menstruating women against heart disease and that postmenopausal women will therefore derive a similar cardiovascular benefit from hormone therapy. The old paradigm is in crisis and must now be replaced, but the authors do not specify what we are shifting to and appear unaware of competing paradigms. The relevance of the findings of the WHI and related studies to the "iron hypothesis,"2 one of the few proposed alternative paradigms . . . [Full Text of this Article]
AUTHOR INFORMATION
Jerome L. Sullivan, MD, PhD
RELATED ARTICLES
Estrogen and Heart Disease: Alternatives to a Paradigm in Crisis—Reply
Judith Hsia, JoAnn E. Manson, Karen C. Johnson, Susan L. Hendrix, Susan R. Heckbert, Sybil Crawford, Charles B. Eaton, and John B. Kostis
Arch Intern Med. 2006;166(19):2160.
EXTRACT
| FULL TEXT
Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative
Judith Hsia, Robert D. Langer, JoAnn E. Manson, Lewis Kuller, Karen C. Johnson, Susan L. Hendrix, Mary Pettinger, Susan R. Heckbert, Nancy Greep, Sybil Crawford, Charles B. Eaton, John B. Kostis, Pat Caralis, Ross Prentice, and for the Women's Health Initiative Investigators
Arch Intern Med. 2006;166(3):357-365.
ABSTRACT
| FULL TEXT
|
